Koninklijke DSM N.V.
KDSKF · OTC
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $38,832,070 | $46,122,568 | $65,619,210 | $54,969,350 |
| - Cash | $2,755,000 | $792,000 | $1,561,000 | $1,640,000 |
| + Debt | $3,064,000 | $3,083,000 | $3,093,000 | $3,124,000 |
| Enterprise Value | $39,141,070 | $48,413,568 | $67,151,210 | $56,453,350 |
| Revenue | – | – | – | – |
| % Growth | – | – | – | – |
| Gross Profit | – | – | – | – |
| % Margin | – | – | – | – |
| EBITDA | – | – | – | – |
| % Margin | – | – | – | – |
| Net Income | – | – | – | – |
| % Margin | – | – | – | – |
| EPS Diluted | – | – | – | – |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |